Document is current
Any future updates will be listed below
-
Authors
Mottolese, Nicola
Loi, Manuela
Trazzi, Stefania
Tassinari, Marianna
Uguagliati, Beatrice
Candini, Giulia
Iqbal, Khalid
Medici, Giorgio
Ciani, Elisabetta https://orcid.org/0000-0003-3130-5168
- License Information
-
More Information
Article History
Received: 24 January 2024
Accepted: 11 November 2024
First Online: 26 November 2024
Declarations
:
: All the experiments were conducted in accordance with the Italian and European Community law for the use of experimental animals and with the approval of the National Bioethical Committee (approval number: n° 184/2022-PR).
: Not applicable.
: KI is cofounder and Chief Scientific Officer of Phanes Biotech Inc. and has several patents on the composition and the use of P021 and is in the process of developing P021 as a therapeutic drug for the treatment of Alzheimer’s disease and related neurodegenerative disorders. Other authors declare no conflicts of interest related to this article.
